Ciprofloxacin (Ciprofloxacin) Patent Expiration, LOE Window & CMS Spending

Ciprofloxacin (Ciprofloxacin) by Chartwell Rx Ll: Multi-Source Generic Molecule, 12 AB generics, $11K 2024 CMS Part D & Medicaid spend, and 5 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorChartwell Rx Ll
FDA Application & PathwayReconciled (ANDA)
Exclusivity / Cliff HorizonMulti-Source Generic Molecule
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors12
2024 CMS Total Public Spend$11K
2024 Medicare Part D Spend$3K
2024 Medicaid Spend$8K
Reported Wholesale Price Change (CA SB 17)5 WAC filings (max 132.4% 2-yr change)